Biotechnology
The Biotechnology industry has a total of 588 stocks, with a combined market cap of $1.3 trillion and total revenue of $115.83 billion.
Market Cap
1.3T
Revenue
115.83B
Profits
-36.06B
PE Ratio
n/a
Profit Margin
-31.13%
Dividend Yield
0.04%
588 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 133.51B | -0.18% | 688,925 | 12.59B |
| 2 | MRNA | Moderna, Inc. | 81.23B | 3.13% | 12,159,936 | 2.23B |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | 74.94B | -0.23% | 804,314 | 15.53B |
| 4 | ARGX | argenx SE | 60.12B | -0.16% | 311,042 | 5.32B |
| 5 | RVMD | Revolution Medicines, Inc. | 43.83B | 1.36% | 1,722,103 | - |
| 6 | ONC | BeOne Medicines AG | 41.53B | -0.47% | 372,800 | 6.13B |
| 7 | ALNY | Alnylam Pharmaceuticals, Inc. | 34.00B | -0.51% | 787,074 | 4.80B |
| 8 | RPRX | Royalty Pharma plc | 33.48B | -0.26% | 2,885,093 | 2.54B |
| 9 | ROIV | Roivant Sciences Ltd. | 26.36B | -1.30% | 6,587,689 | 7.53M |
| 10 | INSM | Insmed Incorporated | 25.25B | -1.73% | 1,668,350 | 1.14B |
| 11 | INCY | Incyte Corporation | 24.97B | -1.30% | 1,718,558 | 5.82B |
| 12 | BNTX | BioNTech SE | 24.76B | -0.51% | 736,903 | 3.03B |
| 13 | GMAB | Genmab A/S | 20.99B | 0.59% | 3,827,541 | 4.13B |
| 14 | JAZZ | Jazz Pharmaceuticals plc | 15.08B | -2.49% | 777,830 | 4.60B |
| 15 | ASND | Ascendis Pharma A/S | 14.98B | -0.86% | 741,863 | 1.20B |
| 16 | EXEL | Exelixis, Inc. | 14.53B | 0.48% | 2,244,165 | 2.44B |
| 17 | SMMT | Summit Therapeutics Inc. | 13.08B | 5.88% | 26,386,092 | - |
| 18 | BBIO | BridgeBio Pharma, Inc. | 12.90B | -0.96% | 3,597,122 | 713.07M |
| 19 | HALO | Halozyme Therapeutics, Inc. | 12.66B | -1.18% | 2,872,922 | 1.66B |
| 20 | CORT | Corcept Therapeutics Incorporated | 12.40B | -0.77% | 962,679 | 830.81M |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.77B | -1.47% | 214,358 | 1.28B |
| 22 | TWST | Twist Bioscience Corporation | 11.67B | 3.64% | 3,680,756 | 431.80M |
| 23 | BMRN | BioMarin Pharmaceutical Inc. | 11.59B | 0.69% | 1,807,465 | 3.41B |
| 24 | TECH | Bio-Techne Corporation | 11.35B | -0.18% | 3,385,176 | 1.22B |
| 25 | KRYS | Krystal Biotech, Inc. | 9.92B | -0.60% | 225,791 | 440.48M |
| 26 | AXSM | Axsome Therapeutics, Inc. | 9.75B | -4.00% | 1,577,597 | 776.57M |
| 27 | IBRX | ImmunityBio, Inc. | 9.36B | 3.64% | 7,350,810 | 165.79M |
| 28 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.36B | 1.21% | 2,895,064 | 669.50M |
| 29 | KYMR | Kymera Therapeutics, Inc. | 9.19B | -1.33% | 448,205 | 105.00M |
| 30 | CYTK | Cytokinetics, Incorporated | 9.13B | -0.79% | 2,401,764 | 67.67M |
| 31 | PTGX | Protagonist Therapeutics, Inc. | 9.12B | -1.03% | 507,933 | 281.99M |
| 32 | CAI | Caris Life Sciences, Inc. | 8.92B | -0.63% | 3,713,822 | 989.61M |
| 33 | PCVX | Vaxcyte, Inc. | 8.44B | -2.71% | 1,493,509 | - |
| 34 | ABVX | ABIVAX Société Anonyme | 8.28B | 1.70% | 1,628,204 | 5.33M |
| 35 | TGTX | TG Therapeutics, Inc. | 7.97B | - | 1,608,126 | 799.54M |
| 36 | PRAX | Praxis Precision Medicines, Inc. | 7.85B | -1.63% | 349,553 | 7.46M |
| 37 | IONS | Ionis Pharmaceuticals, Inc. | 7.63B | 0.70% | 3,885,730 | 874.09M |
| 38 | SYRE | Spyre Therapeutics, Inc. | 7.47B | -1.25% | 1,053,246 | - |
| 39 | IMVT | Immunovant, Inc. | 6.91B | -0.09% | 1,311,430 | - |
| 40 | BLTE | Belite Bio, Inc | 6.71B | 0.44% | 186,874 | - |
| 41 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.59B | -2.89% | 810,796 | 239.92M |
| 42 | IOVA | Iovance Biotherapeutics, Inc. | 6.55B | 31.48% | 74,629,232 | 324.97M |
| 43 | CGON | CG Oncology, Inc. | 6.25B | 1.31% | 1,035,265 | 6.23M |
| 44 | LGND | Ligand Pharmaceuticals Incorporated | 6.19B | -1.19% | 430,955 | 290.54M |
| 45 | SRRK | Scholar Rock Holding Corporation | 5.82B | -2.81% | 1,066,721 | - |
| 46 | KOD | Kodiak Sciences Inc. | 5.72B | 1.33% | 5,802,625 | - |
| 47 | MIRM | Mirum Pharmaceuticals, Inc. | 5.68B | -0.48% | 666,806 | 618.07M |
| 48 | TVTX | Travere Therapeutics, Inc. | 5.65B | -2.57% | 1,546,670 | 591.33M |
| 49 | COGT | Cogent Biosciences, Inc. | 5.50B | -0.63% | 1,704,644 | - |
| 50 | ORKA | Oruka Therapeutics, Inc. | 5.44B | -2.42% | 1,363,318 | - |
| 51 | PTCT | PTC Therapeutics, Inc. | 5.42B | -1.50% | 900,435 | 1.01B |
| 52 | CRSP | CRISPR Therapeutics AG | 5.41B | 3.53% | 1,395,320 | 13.39M |
| 53 | DFTX | Definium Therapeutics, Inc. | 5.13B | -0.52% | 1,967,182 | - |
| 54 | ERAS | Erasca, Inc. | 4.97B | 0.57% | 3,203,318 | - |
| 55 | MANE | Veradermics, Incorporated | 4.92B | 2.45% | 481,702 | - |
| 56 | DNTH | Dianthus Therapeutics, Inc. | 4.88B | -0.76% | 1,033,852 | 1.90M |
| 57 | ABCL | AbCellera Biologics Inc. | 4.80B | 6.47% | 8,703,997 | 66.17M |
| 58 | EWTX | Edgewise Therapeutics, Inc. | 4.26B | -1.51% | 1,920,009 | - |
| 59 | TNGX | Tango Therapeutics, Inc. | 4.12B | 0.49% | 2,992,154 | 53.81M |
| 60 | RLAY | Relay Therapeutics, Inc. | 4.02B | 3.79% | 3,589,026 | 10.35M |
| 61 | PBLS | Parabilis Medicines, Inc. | 3.94B | -2.03% | 453,929 | 148.00K |
| 62 | TLX | Telix Pharmaceuticals Limited | 3.83B | -2.41% | 428,307 | 890.79M |
| 63 | CELC | Celcuity Inc. | 3.79B | -2.84% | 1,221,680 | - |
| 64 | VKTX | Viking Therapeutics, Inc. | 3.71B | -3.69% | 7,511,395 | - |
| 65 | IDYA | IDEAYA Biosciences, Inc. | 3.65B | -0.94% | 815,439 | 234.13M |
| 66 | LEGN | Legend Biotech Corporation | 3.65B | 1.07% | 1,974,366 | 1.27B |
| 67 | XENE | Xenon Pharmaceuticals Inc. | 3.61B | 1.44% | 2,752,535 | 7.50M |
| 68 | ACAD | Acadia Pharmaceuticals Inc. | 3.48B | -1.51% | 2,515,049 | 1.14B |
| 69 | ELVN | Enliven Therapeutics, Inc. | 3.41B | 1.09% | 1,256,223 | - |
| 70 | TARS | Tarsus Pharmaceuticals, Inc. | 3.37B | -0.16% | 417,966 | 606.33M |
| 71 | ARQT | Arcutis Biotherapeutics, Inc. | 3.36B | -2.12% | 2,936,918 | 463.98M |
| 72 | DNLI | Denali Therapeutics Inc. | 3.33B | -0.81% | 1,390,299 | 3.60M |
| 73 | RCUS | Arcus Biosciences, Inc. | 3.27B | 2.56% | 1,094,139 | 117.00M |
| 74 | DYN | Dyne Therapeutics, Inc. | 3.03B | -0.80% | 1,801,514 | - |
| 75 | ZLAB | Zai Lab Limited | 2.91B | 0.93% | 549,095 | 449.61M |
| 76 | PGEN | Precigen, Inc. | 2.88B | 3.07% | 3,674,093 | 85.72M |
| 77 | NAMS | NewAmsterdam Pharma Company N.V. | 2.85B | 0.98% | 1,075,591 | 7.12M |
| 78 | MBX | MBX Biosciences, Inc. | 2.78B | 0.36% | 357,078 | - |
| 79 | IRON | Disc Medicine, Inc. | 2.53B | 1.46% | 783,942 | - |
| 80 | IMNM | Immunome, Inc. | 2.49B | 0.97% | 916,986 | 4.02M |
| 81 | CLDX | Celldex Therapeutics, Inc. | 2.48B | 0.48% | 2,029,408 | 158.00K |
| 82 | NRIX | Nurix Therapeutics, Inc. | 2.46B | 0.02% | 2,275,387 | 36.77M |
| 83 | BEAM | Beam Therapeutics Inc. | 2.45B | 1.20% | 1,637,448 | 156.04M |
| 84 | VERA | Vera Therapeutics, Inc. | 2.33B | -0.38% | 1,457,448 | - |
| 85 | GPCR | Structure Therapeutics Inc. | 2.33B | -6.77% | 888,818 | - |
| 86 | SLS | SELLAS Life Sciences Group, Inc. | 2.32B | -0.69% | 2,706,054 | - |
| 87 | HRMY | Harmony Biosciences Holdings, Inc. | 2.29B | -1.80% | 786,675 | 959.90M |
| 88 | VRDN | Viridian Therapeutics, Inc. | 2.27B | -2.80% | 1,233,587 | 71.13M |
| 89 | ADMA | ADMA Biologics, Inc. | 2.23B | -1.58% | 3,458,110 | 512.28M |
| 90 | PHVS | Pharvaris N.V. | 2.23B | -0.56% | 459,293 | - |
| 91 | ADRX | ADARx Pharmaceuticals, Inc. | 2.20B | 2.71% | 1,299,366 | 6.13M |
| 92 | AUPH | Aurinia Pharmaceuticals Inc. | 2.18B | -0.61% | 734,696 | 311.51M |
| 93 | MLYS | Mineralys Therapeutics, Inc. | 2.16B | -4.49% | 1,719,501 | - |
| 94 | RXRX | Recursion Pharmaceuticals, Inc. | 2.16B | 8.92% | 20,565,937 | 54.86M |
| 95 | VCEL | Vericel Corporation | 2.08B | 0.92% | 526,872 | 306.30M |
| 96 | TRVI | Trevi Therapeutics, Inc. | 2.05B | 0.14% | 2,045,164 | - |
| 97 | NKTR | Nektar Therapeutics | 2.02B | -1.92% | 1,816,393 | 54.59M |
| 98 | BHVN | Biohaven Ltd. | 2.01B | 0.15% | 1,325,329 | - |
| 99 | PVLA | Palvella Therapeutics, Inc. | 2.00B | -0.59% | 214,823 | - |
| 100 | AGIO | Agios Pharmaceuticals, Inc. | 1.99B | -0.36% | 416,406 | 98.34M |
| 101 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.99B | 0.26% | 1,755,082 | 208.78M |
| 102 | GENB | Generate Biomedicines, Inc. | 1.98B | 3.42% | 598,984 | 26.48M |
| 103 | URGN | UroGen Pharma Ltd. | 1.98B | -1.10% | 642,798 | 188.73M |
| 104 | NUVB | Nuvation Bio Inc. | 1.97B | 0.36% | 3,068,395 | 169.90M |
| 105 | SRPT | Sarepta Therapeutics, Inc. | 1.97B | -0.85% | 1,368,437 | 1.97B |
| 106 | ZYME | Zymeworks Inc. | 1.93B | 0.29% | 684,272 | 37.13M |
| 107 | LKFT | Lakefront Biotherapeutics NV | 1.92B | -0.90% | 198,888 | 1.13B |
| 108 | MESO | Mesoblast Limited | 1.91B | 2.55% | 158,023 | 120.25M |
| 109 | FTRE | Fortrea Holdings Inc. | 1.88B | -1.60% | 1,170,629 | 2.68B |
| 110 | XNCR | Xencor, Inc. | 1.86B | -2.34% | 1,620,956 | 104.97M |
| 111 | SEPN | Septerna, Inc. | 1.83B | -1.53% | 564,501 | 98.88M |
| 112 | VIR | Vir Biotechnology, Inc. | 1.80B | 1.33% | 1,573,680 | 303.23M |
| 113 | NVAX | Novavax, Inc. | 1.78B | 0.19% | 4,071,341 | 413.80M |
| 114 | ZBIO | Zenas BioPharma, Inc. | 1.74B | -2.87% | 440,627 | 1.00M |
| 115 | ABSI | Absci Corporation | 1.74B | 6.85% | 3,087,760 | 1.56M |
| 116 | OCUL | Ocular Therapeutix, Inc. | 1.73B | 2.81% | 5,286,682 | 52.06M |
| 117 | QURE | uniQure N.V. | 1.70B | -37.33% | 29,148,842 | 18.67M |
| 118 | GHRS | GH Research PLC | 1.69B | 5.34% | 1,131,961 | - |
| 119 | NTLA | Intellia Therapeutics, Inc. | 1.69B | 5.34% | 4,117,224 | 59.51M |
| 120 | STOK | Stoke Therapeutics, Inc. | 1.67B | 1.49% | 1,076,502 | 27.59M |
| 121 | SNDX | Syndax Pharmaceuticals, Inc. | 1.63B | 2.10% | 1,499,417 | 252.25M |
| 122 | TSHA | Taysha Gene Therapies, Inc. | 1.63B | - | 6,570,231 | 5.49M |
| 123 | NBTX | Nanobiotix S.A. | 1.59B | -3.37% | 163,482 | 13.15M |
| 124 | IMCR | Immunocore Holdings plc | 1.59B | 0.69% | 344,214 | 430.78M |
| 125 | RAPP | Rapport Therapeutics, Inc. | 1.58B | -1.26% | 626,149 | 20.00M |
| 126 | KRSA | Korsana Biosciences, Inc. | 1.55B | 10.28% | 96,837 | - |
| 127 | INBX | Inhibrx Biosciences, Inc. | 1.54B | 3.07% | 240,921 | 1.30M |
| 128 | INVA | Innoviva, Inc. | 1.53B | -0.57% | 555,805 | 440.00M |
| 129 | COAG | Hemab Therapeutics Holdings, Inc. | 1.52B | -1.57% | 452,038 | - |
| 130 | TYRA | Tyra Biosciences, Inc. | 1.51B | 2.47% | 501,793 | - |
| 131 | ANAB | AnaptysBio, Inc. | 1.51B | -0.85% | 677,564 | 106.09M |
| 132 | RARE | Ultragenyx Pharmaceutical Inc. | 1.51B | 6.32% | 4,795,271 | 717.00M |
| 133 | MAZE | Maze Therapeutics, Inc. | 1.50B | 0.63% | 709,487 | 20.00M |
| 134 | BRVE | Braveheart Bio, Inc. | 1.46B | 6.03% | 717,776 | - |
| 135 | AVBP | ArriVent BioPharma, Inc. | 1.46B | 0.82% | 780,003 | - |
| 136 | KLRA | Kailera Therapeutics, Inc. | 1.42B | -1.17% | 694,822 | - |
| 137 | AAPG | Ascentage Pharma Group International | 1.42B | 3.09% | 3,387 | 94.61M |
| 138 | DRTS | Alpha Tau Medical Ltd. | 1.40B | 1.00% | 513,857 | - |
| 139 | OMER | Omeros Corporation | 1.39B | -0.93% | 841,695 | 38.42M |
| 140 | ORIC | ORIC Pharmaceuticals, Inc. | 1.39B | 0.75% | 977,252 | - |
| 141 | KARD | Kardigan, Inc. | 1.37B | -0.81% | 493,600 | - |
| 142 | SVRA | Savara Inc. | 1.29B | 0.20% | 2,034,626 | - |
| 143 | TRAX | First Tracks Biotherapeutics, Inc. | 1.29B | -1.81% | 645,545 | - |
| 144 | DMRA | Damora Therapeutics, Inc. | 1.28B | -0.43% | 376,391 | - |
| 145 | BCAX | Bicara Therapeutics Inc. | 1.23B | -1.28% | 599,779 | - |
| 146 | REPL | Replimune Group, Inc. | 1.22B | 3.50% | 3,920,600 | - |
| 147 | LBRX | LB Pharmaceuticals Inc | 1.20B | -1.61% | 713,377 | - |
| 148 | AVLN | Avalyn Pharma Inc. | 1.20B | -4.31% | 421,890 | - |
| 149 | LTGO | Latigo Biotherapeutics, Inc. | 1.20B | 3.55% | 955,172 | - |
| 150 | IMTX | Immatics N.V. | 1.17B | 0.71% | 644,299 | 47.65M |
| 151 | AKTS | Aktis Oncology, Inc. | 1.10B | 1.76% | 194,637 | 10.06M |
| 152 | VOR | Vor Biopharma Inc. | 1.08B | 0.11% | 1,383,942 | - |
| 153 | ODTX | Odyssey Therapeutics, Inc. | 1.08B | 4.52% | 201,689 | 99.00K |
| 154 | MNKD | MannKind Corporation | 1.07B | -0.30% | 2,381,153 | 393.63M |
| 155 | MGTX | MeiraGTx Holdings plc | 1.07B | 0.18% | 875,926 | 397.50M |
| 156 | SLBT | SL Science Holding Limited | 1.04B | -5.18% | 29,649 | 3.27M |
| 157 | ANRO | Alto Neuroscience, Inc. | 1.04B | -0.30% | 763,380 | - |
| 158 | JANX | Janux Therapeutics, Inc. | 1.04B | 2.23% | 511,702 | 24.00M |
| 159 | ANL | Adlai Nortye Group Ltd. | 1.01B | 2.14% | 63,027 | 18.06M |
| 160 | GLUE | Monte Rosa Therapeutics, Inc. | 1.00B | 0.26% | 545,064 | 28.73M |
| 161 | SPTX | Seaport Therapeutics, Inc. | 1.00B | -4.84% | 288,867 | - |
| 162 | APMD | Apnimed, Inc. | 994.98M | 10.29% | 670,210 | 115.12M |
| 163 | CRVS | Corvus Pharmaceuticals, Inc. | 989.26M | -0.93% | 881,944 | - |
| 164 | CGEM | Cullinan Therapeutics, Inc. | 980.12M | 1.87% | 1,244,361 | - |
| 165 | MLTX | MoonLake Immunotherapeutics | 974.47M | -0.95% | 1,506,991 | - |
| 166 | KURA | Kura Oncology, Inc. | 961.22M | 1.84% | 1,890,157 | 77.23M |
| 167 | ALMS | Alumis Inc. | 943.58M | 1.82% | 1,668,138 | 7.40M |
| 168 | ABUS | Arbutus Biopharma Corporation | 927.91M | -3.50% | 17,557,048 | 181.72M |
| 169 | HELP | Cybin Inc. | 927.86M | 0.87% | 972,391 | - |
| 170 | RIGL | Rigel Pharmaceuticals, Inc. | 913.26M | -0.95% | 182,182 | 276.79M |
| 171 | JBIO | Jade Biosciences, Inc. | 901.81M | -1.18% | 629,533 | - |
| 172 | OBX | Obsidian Therapeutics, Inc. | 900.65M | 9.05% | 378,583 | - |
| 173 | SANA | Sana Biotechnology, Inc. | 871.14M | -0.68% | 3,047,655 | - |
| 174 | SGP | SpyGlass Pharma, Inc. | 850.92M | -1.96% | 67,864 | - |
| 175 | ARDX | Ardelyx, Inc. | 844.75M | -0.59% | 4,434,043 | 450.89M |
| 176 | LXRX | Lexicon Pharmaceuticals, Inc. | 836.52M | -1.05% | 3,946,247 | 41.47M |
| 177 | AVTX | Avalo Therapeutics, Inc. | 835.56M | 3.32% | 1,331,567 | 59.00K |
| 178 | CADL | Candel Therapeutics, Inc. | 832.52M | -2.77% | 963,288 | - |
| 179 | ATTO | Attovia Therapeutics, Inc. | 829.03M | 2.89% | 887,157 | 1.80M |
| 180 | DNA | Ginkgo Bioworks Holdings, Inc. | 805.39M | 14.34% | 4,722,175 | 132.42M |
| 181 | FDMT | 4D Molecular Therapeutics, Inc. | 800.49M | -0.48% | 1,376,232 | 92.01M |
| 182 | GERN | Geron Corporation | 796.67M | -0.80% | 12,498,949 | 204.56M |
| 183 | ACHV | Achieve Life Sciences, Inc. | 791.32M | -0.77% | 1,029,828 | - |
| 184 | DSGN | Design Therapeutics, Inc. | 789.78M | 2.10% | 655,797 | - |
| 185 | ANNX | Annexon, Inc. | 782.96M | 2.99% | 3,706,508 | - |
| 186 | ACRS | Aclaris Therapeutics, Inc. | 777.21M | -2.76% | 2,051,626 | 8.22M |
| 187 | GYRE | Gyre Therapeutics, Inc. | 776.17M | -2.27% | 115,115 | 109.82M |
| 188 | IVA | Inventiva S.A. | 768.41M | -6.80% | 3,832,494 | 2.81M |
| 189 | SLDB | Solid Biosciences Inc. | 767.73M | -1.65% | 1,392,240 | - |
| 190 | IMMX | Immix Biopharma, Inc. | 754.02M | -8.11% | 5,390,234 | - |
| 191 | OLMA | Olema Pharmaceuticals, Inc. | 747.23M | -0.81% | 1,081,253 | - |
| 192 | FTH | Faeth Therapeutics, Inc. | 725.34M | 1.08% | 250,786 | - |
| 193 | VSTM | Verastem, Inc. | 717.26M | 1.93% | 2,677,145 | 87.53M |
| 194 | WVE | Wave Life Sciences, Inc. | 717.26M | -0.82% | 2,765,536 | 65.37M |
| 195 | ETRA | Electra Therapeutics, Inc. | 712.40M | 0.27% | 715,622 | - |
| 196 | PHAR | Pharming Group N.V. | 710.75M | -4.85% | 26,266 | 366.48M |
| 197 | OABI | OmniAb, Inc. | 689.15M | - | 1,391,878 | 38.46M |
| 198 | MDXG | MiMedx Group, Inc. | 680.70M | -0.21% | 901,197 | 355.17M |
| 199 | BLSM | BlossomHill Therapeutics, Inc. | 679.24M | 0.14% | 228,480 | - |
| 200 | DBVT | DBV Technologies S.A. | 676.66M | -0.77% | 199,499 | 5.04M |
| 201 | ZVRA | Zevra Therapeutics, Inc. | 673.41M | 0.35% | 1,340,498 | 136.07M |
| 202 | NVCT | Nuvectis Pharma, Inc. | 669.22M | -1.30% | 160,030 | - |
| 203 | CLYM | Climb Bio, Inc. | 660.52M | -2.04% | 1,140,421 | - |
| 204 | STTK | Shattuck Labs, Inc. | 656.38M | 1.71% | 956,827 | 1.00M |
| 205 | SLN | Silence Therapeutics plc | 650.26M | -3.57% | 884,614 | 615.00K |
| 206 | AURA | Aura Biosciences, Inc. | 637.78M | - | 795,445 | - |
| 207 | CBIO | Crescent Biopharma, Inc. | 631.74M | 1.58% | 684,623 | 11.88M |
| 208 | CRMD | CorMedix Inc. | 618.10M | 0.51% | 817,285 | 462.25M |
| 209 | CTMX | CytomX Therapeutics, Inc. | 599.22M | 2.23% | 4,457,000 | 18.30M |
| 210 | PHAT | Phathom Pharmaceuticals, Inc. | 584.61M | 0.14% | 657,239 | 239.66M |
| 211 | SGMT | Sagimet Biosciences Inc. | 579.94M | -6.14% | 860,048 | - |
| 212 | ALT | Altimmune, Inc. | 577.72M | 0.34% | 2,563,649 | 31.00K |
| 213 | VALN | Valneva SE | 577.43M | -5.10% | 9,535 | 163.30M |
| 214 | NGNE | Neurogene Inc. | 568.12M | -0.32% | 176,722 | 925.00K |
| 215 | MPLT | MapLight Therapeutics, Inc. | 564.09M | -2.87% | 408,312 | - |
| 216 | OCS | Oculis Holding AG | 563.61M | 0.77% | 373,456 | 1.45M |
| 217 | ALLO | Allogene Therapeutics, Inc. | 559.70M | -0.61% | 4,318,917 | 4.64M |
| 218 | PRME | Prime Medicine, Inc. | 549.72M | 7.48% | 3,216,633 | 4.07M |
| 219 | EPRX | Eupraxia Pharmaceuticals Inc. | 541.98M | 1.16% | 645,107 | - |
| 220 | YDES | YD Bio Limited | 539.03M | 7.03% | 344,721 | 1.24M |
| 221 | MNPR | Monopar Therapeutics Inc. | 536.97M | -4.44% | 162,395 | - |
| 222 | AGMB | AgomAb Therapeutics NV | 518.58M | 3.13% | 113,491 | - |
| 223 | DRUG | Bright Minds Biosciences Inc. | 511.00M | -3.72% | 96,741 | - |
| 224 | PBYI | Puma Biotechnology, Inc. | 504.84M | -0.41% | 220,539 | 231.24M |
| 225 | CAPR | Capricor Therapeutics, Inc. | 498.25M | -1.61% | 2,043,693 | 11.13M |
| 226 | OVID | Ovid Therapeutics Inc. | 496.06M | 3.25% | 1,163,592 | 1.58M |
| 227 | AUTL | Autolus Therapeutics plc | 495.06M | - | 1,770,892 | 117.39M |
| 228 | PROK | ProKidney Corp. | 492.79M | 1.24% | 1,003,272 | 818.00K |
| 229 | RGNX | REGENXBIO Inc. | 491.80M | -0.27% | 1,606,592 | 174.48M |
| 230 | ARVN | Arvinas, Inc. | 490.40M | -0.13% | 496,011 | 316.70M |
| 231 | ASMB | Assembly Biosciences, Inc. | 478.07M | -0.55% | 229,736 | 74.85M |
| 232 | ENTX | Entera Bio Ltd. | 465.75M | - | 160,824 | 42.00K |
| 233 | TECX | Tectonic Therapeutic, Inc. | 456.28M | -0.72% | 1,050,103 | - |
| 234 | PRTA | Prothena Corporation plc | 450.74M | 0.69% | 602,274 | 54.53M |
| 235 | AGEN | Agenus Inc. | 445.25M | 4.88% | 1,501,456 | 132.69M |
| 236 | DMAC | DiaMedica Therapeutics Inc. | 442.19M | -1.44% | 231,059 | - |
| 237 | SPRY | ARS Pharmaceuticals, Inc. | 437.57M | 6.54% | 1,274,703 | 116.93M |
| 238 | SCTX | Scribe Therapeutics Inc. | 436.00M | 5.79% | 671,395 | 33.30M |
| 239 | CTNM | Contineum Therapeutics, Inc. | 432.64M | -9.66% | 856,143 | - |
| 240 | RZLT | Rezolute, Inc. | 429.03M | -2.15% | 1,518,965 | - |
| 241 | EIKN | Eikon Therapeutics, Inc. | 428.45M | - | 334,819 | - |
| 242 | KYTX | Kyverna Therapeutics, Inc. | 423.01M | 0.29% | 749,498 | - |
| 243 | AVIR | Atea Pharmaceuticals, Inc. | 415.46M | -0.38% | 298,326 | - |
| 244 | IRD | Opus Genetics, Inc. | 412.24M | -1.88% | 1,525,569 | 9.86M |
| 245 | PRLD | Prelude Therapeutics Incorporated | 407.86M | 1.28% | 457,879 | 22.42M |
| 246 | TTRX | Turn Therapeutics Inc. | 399.46M | 2.84% | 79,533 | - |
| 247 | RLMD | Relmada Therapeutics, Inc. | 397.88M | -1.58% | 863,494 | - |
| 248 | EDIT | Editas Medicine, Inc. | 397.77M | 3.19% | 1,569,545 | 47.01M |
| 249 | GALT | Galectin Therapeutics Inc. | 394.32M | -0.51% | 149,833 | - |
| 250 | ARCT | Arcturus Therapeutics Holdings Inc. | 389.40M | -5.26% | 435,818 | 29.37M |
| 251 | CCCC | C4 Therapeutics, Inc. | 385.07M | 0.48% | 1,553,985 | 35.04M |
| 252 | ZURA | Zura Bio Limited | 383.32M | -2.44% | 2,043,847 | - |
| 253 | INDP | Indaptus Therapeutics, Inc. | 379.74M | -13.37% | 590,367 | - |
| 254 | FENC | Fennec Pharmaceuticals Inc. | 378.73M | -1.37% | 117,741 | 59.22M |
| 255 | SRZN | Surrozen, Inc. | 375.88M | 7.89% | 557,391 | 11.51M |
| 256 | VTVT | vTv Therapeutics Inc. | 372.74M | -1.70% | 85,142 | 36.84M |
| 257 | OCGN | Ocugen, Inc. | 369.63M | 5.83% | 7,128,723 | 4.58M |
| 258 | ENTA | Enanta Pharmaceuticals, Inc. | 368.15M | 0.20% | 322,818 | 65.26M |
| 259 | IKT | Inhibikase Therapeutics, Inc. | 367.79M | -1.46% | 400,251 | 1.00 |
| 260 | OBIO | Orchestra BioMed Holdings, Inc. | 365.44M | 3.23% | 237,089 | 31.98M |
| 261 | VOGX | Vogenx, Inc. | 361.20M | 10.52% | 137,987 | - |
| 262 | ARTV | Artiva Biotherapeutics, Inc. | 343.70M | -0.28% | 450,549 | 251.00K |
| 263 | BNTC | Benitec Biopharma Inc. | 340.11M | -2.69% | 110,966 | - |
| 264 | CABA | Cabaletta Bio, Inc. | 335.70M | -1.00% | 4,193,307 | - |
| 265 | LRMR | Larimar Therapeutics, Inc. | 327.76M | -0.95% | 1,041,471 | - |
| 266 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 314.28M | 2.89% | 537,350 | - |
| 267 | VNDA | Vanda Pharmaceuticals Inc. | 304.13M | -2.71% | 652,952 | 215.72M |
| 268 | EVMN | Evommune, Inc. | 303.04M | -0.48% | 807,597 | 10.00M |
| 269 | IPSC | Century Therapeutics, Inc. | 298.77M | -1.20% | 353,516 | 109.16M |
| 270 | ABEO | Abeona Therapeutics Inc. | 295.07M | -2.46% | 1,253,704 | 25.52M |
| 271 | EYPT | EyePoint, Inc. | 294.85M | 3.32% | 2,085,645 | 2.79M |
| 272 | CUVL | Clinuvel Pharmaceuticals Limited | 294.75M | 2.09% | 2,206 | 65.05M |
| 273 | SABS | SAB Biotherapeutics, Inc. | 292.98M | 0.16% | 1,061,454 | 114.70K |
| 274 | XFOR | X4 Pharmaceuticals, Inc. | 287.53M | -3.81% | 1,710,135 | 15.85M |
| 275 | FATE | Fate Therapeutics, Inc. | 285.17M | - | 1,443,069 | 6.49M |
| 276 | RCKT | Rocket Pharmaceuticals, Inc. | 284.32M | -0.77% | 1,071,165 | - |
| 277 | UPB | Upstream Bio, Inc. | 284.26M | -2.08% | 784,210 | 3.16M |
| 278 | QTTB | Q32 Bio Inc. | 283.70M | 3.25% | 845,095 | 53.74M |
| 279 | FULC | Fulcrum Therapeutics, Inc. | 282.30M | -0.54% | 1,842,657 | 80.00M |
| 280 | LXEO | Lexeo Therapeutics, Inc. | 280.59M | 8.92% | 6,377,015 | - |
| 281 | IFRX | InflaRx N.V. | 272.63M | 1.65% | 268,403 | -11.54K |
| 282 | GLSI | Greenwich LifeSciences, Inc. | 269.79M | -1.13% | 65,832 | - |
| 283 | IMRX | Immuneering Corporation | 267.20M | -0.72% | 574,365 | - |
| 284 | STRO | Sutro Biopharma, Inc. | 266.96M | 0.44% | 202,391 | 45.70M |
| 285 | VCRE | Vicore Pharma Holding AB (publ) | 263.91M | -0.73% | 65,526 | 412.09K |
| 286 | ACIU | AC Immune SA | 258.51M | -0.38% | 139,225 | 21.67M |
| 287 | ZNTL | Zentalis Pharmaceuticals, Inc. | 257.03M | 4.42% | 4,779,668 | 26.87M |
| 288 | BCYC | Bicycle Therapeutics plc | 255.47M | -1.62% | 206,180 | 61.21M |
| 289 | PALI | Palisade Bio, Inc. | 252.69M | -3.33% | 2,165,021 | 500.00K |
| 290 | IVVD | Invivyd, Inc. | 250.57M | -10.52% | 30,247,440 | 58.37M |
| 291 | CAMP | Camp4 Therapeutics Corporation | 245.99M | 1.82% | 172,518 | 4.22M |
| 292 | PYXS | Pyxis Oncology, Inc. | 241.88M | - | 178,895 | 11.04M |
| 293 | MGNX | MacroGenics, Inc. | 240.15M | -7.14% | 616,430 | 175.14M |
| 294 | LCTX | Lineage Cell Therapeutics, Inc. | 239.63M | -2.42% | 2,513,675 | 13.08M |
| 295 | SLGL | Sol-Gel Technologies Ltd. | 236.55M | 4.03% | 30,672 | 1.80M |
| 296 | LYEL | Lyell Immunopharma, Inc. | 235.98M | -1.13% | 140,818 | 27.00K |
| 297 | PRQR | ProQR Therapeutics N.V. | 232.85M | - | 382,196 | 21.05M |
| 298 | SION | Sionna Therapeutics, Inc. | 232.84M | 0.59% | 797,862 | - |
| 299 | TRDA | Entrada Therapeutics, Inc. | 225.72M | 0.64% | 268,574 | 4.69M |
| 300 | YARW | Yarrow Bioscience, Inc. | 225.07M | 0.79% | 100,647 | - |
| 301 | CGEN | Compugen Ltd. | 222.60M | 0.86% | 117,126 | 74.00M |
| 302 | KROS | Keros Therapeutics, Inc. | 221.87M | -0.80% | 118,349 | 15.01M |
| 303 | RNAC | Cartesian Therapeutics, Inc. | 219.05M | 0.42% | 131,742 | 1.48M |
| 304 | AVXL | Anavex Life Sciences Corp. | 218.76M | 0.43% | 1,756,142 | - |
| 305 | PLX | Protalix BioTherapeutics, Inc. | 216.74M | - | 840,903 | 80.62M |
| 306 | ADAG | Adagene Inc. | 215.53M | 0.31% | 492,293 | 9.29M |
| 307 | WHWK | Whitehawk Therapeutics, Inc. | 212.64M | -0.80% | 221,858 | 7.15M |
| 308 | FHTX | Foghorn Therapeutics Inc. | 209.04M | - | 376,210 | 36.74M |
| 309 | ALEC | Alector, Inc. | 208.80M | -2.60% | 960,737 | 13.86M |
| 310 | NGEN | NervGen Pharma Corp. | 206.44M | 2.13% | 560,128 | - |
| 311 | ELDN | Eledon Pharmaceuticals, Inc. | 203.35M | -5.30% | 712,373 | - |
| 312 | CMPX | Compass Therapeutics, Inc. | 198.10M | -0.90% | 2,913,536 | 850.00K |
| 313 | ORMP | Oramed Pharmaceuticals Inc. | 195.09M | -1.26% | 170,662 | 2.00M |
| 314 | ANTX | AN2 Therapeutics, Inc. | 192.08M | 1.60% | 178,838 | - |
| 315 | TARA | Protara Therapeutics, Inc. | 189.70M | -1.23% | 391,404 | - |
| 316 | ACOG | Alpha Cognition Inc. | 189.69M | 1.28% | 61,476 | 15.26M |
| 317 | CNTN | Canton Strategic Holdings, Inc. | 189.64M | -11.52% | 875,924 | 1.50M |
| 318 | NKTX | Nkarta, Inc. | 187.66M | -1.87% | 524,584 | - |
| 319 | ALXO | ALX Oncology Holdings Inc. | 186.67M | -2.88% | 1,681,508 | - |
| 320 | CUE | Cue Biopharma, Inc. | 185.32M | -7.07% | 283,766 | 37.66M |
| 321 | VRXA | Veraxa Biotech AG | 185.24M | -4.38% | 53,072 | 29.54K |
| 322 | MSLE | Satellos Bioscience Inc. | 182.32M | -2.38% | 433,303 | - |
| 323 | CHRS | Coherus Oncology, Inc. | 182.31M | 3.51% | 1,346,697 | 50.94M |
| 324 | MDWD | MediWound Ltd. | 178.16M | -0.93% | 30,248 | 11.86M |
| 325 | NAUT | Nautilus Biotechnology, Inc. | 173.70M | 22.97% | 21,698,807 | 190.00K |
| 326 | DTIL | Precision BioSciences, Inc. | 170.58M | -0.96% | 154,143 | 45.06M |
| 327 | TNXP | Tonix Pharmaceuticals Holding Corp. | 165.51M | -2.53% | 394,328 | 29.10M |
| 328 | VYGR | Voyager Therapeutics, Inc. | 162.67M | -2.22% | 628,607 | 34.46M |
| 329 | ABOS | Acumen Pharmaceuticals, Inc. | 162.35M | -2.39% | 1,086,771 | - |
| 330 | PEPG | PepGen Inc. | 162.07M | -9.65% | 2,296,550 | - |
| 331 | NERV | Minerva Neurosciences, Inc. | 159.95M | -1.47% | 33,337 | - |
| 332 | NBP | NovaBridge Biosciences | 158.92M | 0.74% | 294,567 | - |
| 333 | OTLK | Outlook Therapeutics, Inc. | 152.33M | 0.74% | 4,583,135 | -1.16M |
| 334 | MOLN | Molecular Partners AG | 151.85M | 1.04% | 669 | 856.30K |
| 335 | MENS | Jyong Biotech Ltd. | 150.69M | 3.05% | 17,148 | - |
| 336 | HUMA | Humacyte, Inc. | 147.98M | -2.65% | 3,612,485 | 2.12M |
| 337 | CDXS | Codexis, Inc. | 147.83M | -0.74% | 606,368 | 77.68M |
| 338 | IPHA | Innate Pharma S.A. | 145.25M | -5.88% | 31,789 | 11.21M |
| 339 | RNA | Atrium Therapeutics, Inc. | 144.03M | - | 158,802 | 35.84M |
| 340 | KRRO | Korro Bio, Inc. | 140.78M | 0.53% | 92,866 | 2.38M |
| 341 | SPRB | Spruce Biosciences, Inc. | 135.85M | -0.51% | 84,184 | 697.00K |
| 342 | KZIA | Kazia Therapeutics Limited | 133.61M | 1.56% | 176,351 | 1.27M |
| 343 | ARMP | Armata Pharmaceuticals, Inc. | 133.48M | -5.03% | 80,250 | 5.54M |
| 344 | TNYA | Tenaya Therapeutics, Inc. | 132.99M | 0.56% | 1,735,816 | 1.34M |
| 345 | CRBU | Caribou Biosciences, Inc. | 132.94M | 0.81% | 553,395 | 10.04M |
| 346 | HURA | TuHURA Biosciences, Inc. | 131.91M | -0.96% | 228,998 | - |
| 347 | ENGN | enGene Therapeutics Inc. | 130.68M | -1.02% | 393,183 | - |
| 348 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 128.23M | -4.19% | 786,178 | - |
| 349 | NMRA | Neumora Therapeutics, Inc. | 127.32M | -2.05% | 1,249,382 | - |
| 350 | UNCY | Unicycive Therapeutics, Inc. | 126.74M | -1.94% | 2,306,547 | - |
| 351 | NRXP | NRx Pharmaceuticals, Inc. | 126.33M | 1.74% | 515,765 | 3.39M |
| 352 | TLSA | Tiziana Life Sciences Ltd | 123.32M | -2.73% | 511,324 | - |
| 353 | IMUX | Immunic, Inc. | 121.57M | -6.31% | 434,724 | - |
| 354 | LENZ | LENZ Therapeutics, Inc. | 121.28M | -2.53% | 645,153 | 21.48M |
| 355 | SEER | Seer, Inc. | 119.05M | 5.91% | 583,347 | 14.22M |
| 356 | CBUS | Cibus, Inc. | 118.46M | 5.44% | 270,245 | 4.35M |
| 357 | COYA | Coya Therapeutics, Inc. | 117.99M | 1.00% | 75,459 | 8.02M |
| 358 | AARD | Aardvark Therapeutics, Inc. | 117.08M | 1.52% | 39,649 | - |
| 359 | MIST | Milestone Pharmaceuticals Inc. | 115.55M | 3.09% | 933,567 | 2.34M |
| 360 | INO | Inovio Pharmaceuticals, Inc. | 114.77M | -5.13% | 3,079,830 | 65.34K |
| 361 | RANI | Rani Therapeutics Holdings, Inc. | 111.56M | 3.13% | 405,579 | 4.88M |
| 362 | VANI | Vivani Medical, Inc. | 110.95M | -1.60% | 82,914 | - |
| 363 | GNLX | Genelux Corporation | 109.79M | -0.81% | 164,896 | 8.00K |
| 364 | PMVP | PMV Pharmaceuticals, Inc. | 107.98M | 5.15% | 550,858 | - |
| 365 | PYPD | PolyPid Ltd. | 107.45M | -0.38% | 66,017 | - |
| 366 | BDTX | Black Diamond Therapeutics, Inc. | 107.44M | 2.19% | 439,427 | 70.00M |
| 367 | TVGN | Tevogen Inc. | 106.22M | -0.15% | 1,371 | - |
| 368 | TENX | Tenax Therapeutics, Inc. | 105.40M | -0.54% | 2,269,860 | - |
| 369 | OKUR | OnKure Therapeutics, Inc. | 105.29M | -5.80% | 339,834 | - |
| 370 | CLLS | Cellectis S.A. | 104.70M | -0.68% | 32,664 | 63.82M |
| 371 | CNXU | Conexeu Sciences Inc. | 104.65M | -1.59% | 241,521 | - |
| 372 | PLYX | Polaryx Therapeutics, Inc. | 103.18M | 1.47% | 30,986 | - |
| 373 | EQ | Equillium, Inc. | 102.72M | -3.57% | 316,252 | 4.39M |
| 374 | NTRB | Nutriband Inc. | 100.28M | 0.24% | 136,673 | 1.62M |
| 375 | ANIX | Anixa Biosciences, Inc. | 99.08M | 2.15% | 183,176 | - |
| 376 | NRXS | NeurAxis, Inc. | 97.45M | 4.86% | 101,892 | 5.32M |
| 377 | PMN | ProMIS Neurosciences, Inc. | 95.37M | -0.14% | 16,920 | - |
| 378 | MNOV | MediciNova, Inc. | 94.50M | -8.57% | 599,146 | 920.48K |
| 379 | RLYB | Rallybio Corporation | 91.50M | 1.06% | 16,684 | 646.00K |
| 380 | BMEA | Biomea Fusion, Inc. | 91.33M | -2.33% | 1,556,114 | - |
| 381 | CRDF | Cardiff Oncology, Inc. | 91.02M | -2.50% | 352,969 | 508.00K |
| 382 | CGTX | Cognition Therapeutics, Inc. | 90.76M | 1.71% | 516,686 | - |
| 383 | ICCC | ImmuCell Corporation | 90.28M | 0.61% | 2,805 | 30.68M |
| 384 | ACRV | Acrivon Therapeutics, Inc. | 89.13M | 0.97% | 132,582 | - |
| 385 | ONCY | Oncolytics Biotech Inc. | 86.01M | 1.73% | 784,326 | - |
| 386 | GUTS | Fractyl Health, Inc. | 82.77M | 10.40% | 1,607,643 | 3.00K |
| 387 | NTHI | NeOnc Technologies Holdings, Inc. | 82.03M | 4.43% | 180,825 | 39.99K |
| 388 | ATRA | Atara Biotherapeutics, Inc. | 80.80M | -3.82% | 56,450 | 6.19M |
| 389 | TELO | Telomir Pharmaceuticals, Inc. | 80.47M | -2.50% | 33,383 | - |
| 390 | PTHS | Pelthos Therapeutics Inc. | 80.09M | -1.55% | 9,103 | 43.30M |
| 391 | ALDX | Aldeyra Therapeutics, Inc. | 79.63M | 13.79% | 5,458,404 | - |
| 392 | VRCA | Verrica Pharmaceuticals Inc. | 76.62M | -3.04% | 3,647 | 30.32M |
| 393 | IBIO | iBio, Inc. | 75.24M | - | 236,442 | 100.00K |
| 394 | OSTX | OS Therapies Incorporated | 74.26M | -2.42% | 461,104 | - |
| 395 | ACET | Adicet Bio, Inc. | 73.52M | 7.56% | 668,199 | - |
| 396 | FBIO | Fortress Biotech, Inc. | 73.37M | 1.38% | 257,151 | 68.47M |
| 397 | GANX | Gain Therapeutics, Inc. | 73.32M | -5.08% | 1,152,829 | - |
| 398 | OKYO | OKYO Pharma Limited | 71.37M | -0.73% | 44,039 | - |
| 399 | CING | Cingulate Inc. | 71.33M | 1.76% | 66,597 | - |
| 400 | RNXT | RenovoRx, Inc. | 70.85M | 1.29% | 355,662 | 1.98M |
| 401 | GOSS | Gossamer Bio, Inc. | 70.76M | 0.52% | 383,934 | 53.29M |
| 402 | MAIA | MAIA Biotechnology, Inc. | 69.95M | -2.54% | 658,542 | - |
| 403 | SPRO | Spero Therapeutics, Inc. | 69.88M | 0.84% | 334,903 | 47.00M |
| 404 | KLRS | Kalaris Therapeutics, Inc. | 69.03M | 1.93% | 51,803 | - |
| 405 | BSEM | BioStem Technologies, Inc. | 68.36M | -5.43% | 49,906 | 34.59M |
| 406 | RNTX | Rein Therapeutics Inc. | 68.15M | 9.57% | 388,478 | - |
| 407 | PLRX | Pliant Therapeutics, Inc. | 66.88M | - | 214,496 | - |
| 408 | CSBR | Champions Oncology, Inc. | 66.67M | -2.84% | 15,116 | 60.66M |
| 409 | ALPS | Alps Group Inc | 66.54M | -0.03% | 28,050 | 3.74M |
| 410 | XBIT | XBiotech Inc. | 66.46M | 1.40% | 8,598 | - |
| 411 | HYFT | MindWalk Holdings Corp. | 65.01M | 2.99% | 103,010 | 11.57M |
| 412 | INKT | MiNK Therapeutics, Inc. | 62.56M | 1.24% | 21,955 | - |
| 413 | CNTB | Connect Biopharma Holdings Limited | 62.47M | -8.15% | 1,604,527 | 2.95M |
| 414 | ELOX | Eloxx Pharmaceuticals, Inc. | 62.24M | 2.80% | 6,066 | - |
| 415 | HYPD | Hyperion DeFi, Inc. | 62.00M | 1.92% | 354,716 | 1.40M |
| 416 | ATHE | Alterity Therapeutics Limited | 61.58M | 4.57% | 21,410 | 2.50M |
| 417 | MREO | Mereo BioPharma Group plc | 59.60M | 0.86% | 1,549,654 | 500.00K |
| 418 | XLO | Xilio Therapeutics, Inc. | 58.81M | -1.24% | 3,114 | 64.09M |
| 419 | CLNN | Clene Inc. | 58.28M | 0.99% | 70,377 | 197.00K |
| 420 | BOLD | Boundless Bio, Inc. | 58.23M | -1.92% | 51,995 | - |
| 421 | HRTX | Heron Therapeutics, Inc. | 58.09M | 4.87% | 3,358,674 | 151.18M |
| 422 | EXOZ | eXoZymes, Inc. | 56.62M | 1.67% | 2,026 | -700.00 |
| 423 | ANVS | Annovis Bio, Inc. | 55.39M | -5.80% | 812,053 | - |
| 424 | INMB | INmune Bio Inc. | 54.40M | -2.00% | 286,553 | 50.00K |
| 425 | APLM | Apollomics, Inc. | 52.97M | 1.15% | 10,139 | 8.84M |
| 426 | SER | Serina Therapeutics, Inc. | 52.83M | 3.48% | 15,252 | 130.00K |
| 427 | IMA | ImageneBio, Inc. | 51.99M | -1.29% | 7,255 | 800.00K |
| 428 | ELTX | Elicio Therapeutics, Inc. | 48.36M | -0.54% | 452,391 | - |
| 429 | EDSA | Edesa Biotech, Inc. | 48.10M | -2.47% | 41,245 | - |
| 430 | IBO | Impact BioMedical Inc. | 47.85M | -0.18% | 8,735 | 35.00K |
| 431 | TIL | Instil Bio, Inc. | 47.84M | 0.20% | 3,022 | - |
| 432 | DWTX | Dogwood Therapeutics, Inc. | 45.89M | -0.74% | 79,579 | - |
| 433 | FLNA | Filana Therapeutics, Inc. | 44.67M | 8.38% | 1,202,402 | - |
| 434 | GRCE | Grace Therapeutics, Inc. | 44.39M | -0.47% | 130,160 | - |
| 435 | HOWL | Werewolf Therapeutics, Inc. | 44.23M | -2.15% | 942,196 | 21.00M |
| 436 | VERU | Veru Inc. | 43.65M | 1.39% | 33,081 | 16.89M |
| 437 | CRVO | CervoMed Inc. | 43.54M | 7.87% | 455,792 | 331.30K |
| 438 | MGX | Metagenomi Therapeutics, Inc. | 42.69M | -0.88% | 56,684 | 13.56M |
| 439 | LITS | Lite Strategy, Inc. | 41.81M | 1.10% | 627,663 | - |
| 440 | PDSB | PDS Biotechnology Corporation | 41.58M | -3.00% | 2,647,239 | - |
| 441 | CELU | Celularity Inc. | 39.66M | -2.14% | 38,937 | 27.12M |
| 442 | ATNM | Actinium Pharmaceuticals, Inc. | 35.84M | -3.39% | 60,339 | 35.09M |
| 443 | BCTX | BriaCell Therapeutics Corp. | 35.54M | -1.81% | 181,735 | - |
| 444 | IMMP | Immutep Limited | 35.16M | -3.48% | 33,944 | 13.79M |
| 445 | ALGS | Aligos Therapeutics, Inc. | 35.09M | 1.44% | 10,267 | 31.52M |
| 446 | MCRB | Seres Therapeutics, Inc. | 34.60M | -1.14% | 71,192 | 1.88M |
| 447 | LONA | LeonaBio, Inc. | 33.07M | 22.30% | 439,087 | - |
| 448 | BYSI | BeyondSpring Inc. | 31.80M | -30.96% | 2,389,917 | 1.88M |
| 449 | QNCX | Quince Therapeutics, Inc. | 31.70M | 7.48% | 21,761 | - |
| 450 | CVM | CEL-SCI Corporation | 31.48M | 5.29% | 74,125 | - |
| 451 | QNTM | Quantum BioPharma Ltd. | 30.89M | -3.54% | 115,134 | - |
| 452 | ATYR | aTyr Pharma, Inc. | 30.18M | 3.36% | 3,853,413 | 190.00K |
| 453 | NNVC | NanoViricides, Inc. | 29.61M | -13.33% | 946,957 | - |
| 454 | CNTX | Context Therapeutics Inc. | 29.31M | -2.24% | 849,388 | - |
| 455 | IGC | IGC Pharma, Inc. | 27.66M | -2.37% | 510,760 | 1.11M |
| 456 | RNAZ | TransCode Therapeutics, Inc. | 27.60M | -4.68% | 10,938 | - |
| 457 | KYNB | Kyntra Bio, Inc. | 27.49M | -1.59% | 18,046 | 4.62M |
| 458 | KPTI | Karyopharm Therapeutics Inc. | 27.33M | -25.62% | 1,794,851 | 146.62M |
| 459 | EVAX | Evaxion A/S | 27.27M | 0.93% | 38,132 | 7.49M |
| 460 | ABVC | ABVC BioPharma, Inc. | 26.96M | -0.95% | 183,975 | 797.92K |
| 461 | PLRZ | Polyrizon Ltd. | 25.20M | 1.25% | 8,732 | - |
| 462 | QNRX | Quoin Pharmaceuticals, Ltd. | 23.44M | -7.22% | 64,359 | - |
| 463 | GRDX | GridAI Technologies Corp. | 23.08M | -6.05% | 51,177 | - |
| 464 | NXTC | NextCure, Inc. | 22.18M | -4.63% | 55,395 | - |
| 465 | COCP | Cocrystal Pharma, Inc. | 21.57M | -7.44% | 121,017 | 330.00K |
| 466 | TCRX | TScan Therapeutics, Inc. | 21.52M | -6.62% | 753,473 | 7.11M |
| 467 | RADX | Radiopharm Theranostics Limited | 21.31M | - | 43,392 | 9.34M |
| 468 | JSPR | Jasper Therapeutics, Inc. | 20.81M | -0.10% | 915,498 | - |
| 469 | PBM | Psyence Biomedical Ltd. | 20.71M | -4.15% | 25,905 | - |
| 470 | ESLA | Estrella Immunopharma, Inc. | 20.01M | 6.65% | 25,889 | - |
| 471 | ATOS | Atossa Therapeutics, Inc. | 19.86M | 1.53% | 83,318 | - |
| 472 | NEUP | Neuphoria Therapeutics Inc. | 19.32M | -2.19% | 14,984 | 1.17M |
| 473 | AKTX | Akari Therapeutics, Plc | 18.59M | -2.65% | 50,314 | - |
| 474 | PTN | Palatin Technologies, Inc. | 18.34M | -4.80% | 32,880 | 13.19M |
| 475 | MRKR | Marker Therapeutics, Inc. | 18.34M | -2.22% | 90,886 | 3.55M |
| 476 | LPCN | Lipocine Inc. | 17.81M | 3.35% | 24,256 | 1.57M |
| 477 | CLRB | Cellectar Biosciences, Inc. | 17.20M | -0.55% | 86,032 | - |
| 478 | NCEL | NewcelX Ltd. | 17.16M | 1.71% | 3,101 | - |
| 479 | TVRD | Tvardi Therapeutics, Inc. | 17.07M | -3.76% | 254,039 | - |
| 480 | DYAI | Dyadic International, Inc. | 16.98M | 0.22% | 117,058 | 3.80M |
| 481 | KPRX | Kiora Pharmaceuticals, Inc. | 16.48M | -3.00% | 6,560 | 20.00K |
| 482 | ACTU | Actuate Therapeutics, Inc. | 16.47M | -6.82% | 106,428 | - |
| 483 | KTTA | Pasithea Therapeutics Corp. | 16.37M | 2.08% | 141,485 | - |
| 484 | ICU | SeaStar Medical Holding Corporation | 15.69M | 4.71% | 135,120 | 1.71M |
| 485 | BCDA | BioCardia, Inc. | 15.59M | -0.96% | 117,275 | 3.00K |
| 486 | ALLR | Allarity Therapeutics, Inc. | 15.36M | -0.34% | 167,397 | 345.00K |
| 487 | CTXR | Citius Pharmaceuticals, Inc. | 15.22M | 1.00% | 148,830 | 7.11M |
| 488 | PASG | Passage Bio, Inc. | 14.90M | -0.96% | 24,691 | - |
| 489 | HIND | Vyome Holdings, Inc. | 14.18M | -0.49% | 8,571 | 129.73K |
| 490 | CNSY | Cerenome, Inc. | 14.12M | -7.92% | 238,220 | 4.20M |
| 491 | NIKI | Niki BioSolutions, Inc. | 13.93M | 0.85% | 14,307 | - |
| 492 | LTRN | Lantern Pharma Inc. | 13.87M | -0.46% | 359,721 | - |
| 493 | TPST | Tempest Therapeutics, Inc. | 13.40M | -2.56% | 154,607 | - |
| 494 | LSTA | Lisata Therapeutics, Inc. | 13.25M | -2.00% | 50,683 | 100.00K |
| 495 | VTGN | Vistagen Therapeutics, Inc. | 13.22M | 0.34% | 1,946,194 | 2.50M |
| 496 | AEON | AEON Biopharma, Inc. | 12.92M | -0.99% | 193,360 | - |
| 497 | INAB | IN8bio, Inc. | 12.82M | 4.84% | 62,208 | - |
| 498 | DARE | Daré Bioscience, Inc. | 12.46M | 8.67% | 644,379 | 1.37M |
| 499 | PLUR | Pluri Inc. | 12.46M | 4.02% | 14,579 | 1.02M |
| 500 | GTBP | GT Biopharma, Inc. | 12.41M | 1.10% | 33,485 | - |